Type your tag names separated by a space and hit enter

Abciximab (Reopro):

General

Abciximab (Reopro): Glycoprotein IIb/IIIa inhibitor preventing platelet adhesion and aggregation.

Indications

Indications: Prevent thrombus formation peri-PTCA and poststent placement.

Administration guidelines

Administration guidelines

  1. Standard concentration: 9 mg/250 mL 0.9% sodium chloride.
  2. The IV tubing must have a filter on it (0.2- or 0.22-μm low-protein-binding filter) and no other medications should be piggybacked through this line.
  3. Loading dose (straight drug): 0.25 mg/kg administered 10 to 60 minutes prior to PCI. Withdraw through the 0.2- or 0.22-μm low-protein-binding filter the appropriate amount of abciximab for the patient's weight. Hypotension may occur with bolus dose.
  4. Maintenance at a rate of 0.125 μg/kg/min to a max of 10 μg/min (17 mL/h) for 12 hours. To prepare, withdraw 4.5 mL (9 mg) of abciximab through 0.2- or 0.22-μm low-protein-binding filter and inject into 250-mL bag of 0.9% sodium chloride.

Abciximab (Reopro): is a sample topic from the Clinical Anesthesia Procedures.

To view other topics, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Learn more.

Citation

Pino, Richard M., editor. "Abciximab (Reopro):" Clinical Anesthesia Procedures, 9th ed., Wolters Kluwer, 2019. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728001/all/Abciximab__Reopro_:.
Abciximab (Reopro): In: Pino RM, ed. Clinical Anesthesia Procedures. 9th ed. Wolters Kluwer; 2019. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728001/all/Abciximab__Reopro_:. Accessed March 22, 2019.
Abciximab (Reopro): (2019). In Pino, R. M. (Ed.), Clinical Anesthesia Procedures. Available from https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728001/all/Abciximab__Reopro_:
Abciximab (Reopro): [Internet]. In: Pino RM, editors. Clinical Anesthesia Procedures. Wolters Kluwer; 2019. [cited 2019 March 22]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728001/all/Abciximab__Reopro_:.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Abciximab (Reopro): ID - 728001 ED - Pino,Richard M, BT - Clinical Anesthesia Procedures UR - https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728001/all/Abciximab__Reopro_: PB - Wolters Kluwer ET - 9 DB - Anesthesia Central DP - Unbound Medicine ER -